Barbara Farrell1, Roland Grad2, Pam Howell3, Tammie Quast3, Emily Reeve4. 1. Bruyère Research Institute and Department of Family Medicine, University of Ottawa, Ottawa, Canada | and School of Pharmacy, University of Waterloo, Waterloo, Canada. 2. McGill University Department of Family Medicine, Montreal, Quebec, Canada. 3. Bruyère Research Institute, Ottawa, Ontario, Canada. 4. Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia | Geriatric Medicine Research, Faculty of Medicine, Dalhousie University and Nova Scotia Health Authority, Halifax, NS, Canada | College of Pharmacy, Dalhousie University, Halifax, NS, Canada.
Abstract
INTRODUCTION: We developed a new channel on a mobile app as a continuing education tool to augment the use of deprescribing guideline content in clinical practice. In this research brief, we describe the reach and adoption of channel content, as well as user feedback. METHODS: Using Google Analytics, we counted page views of the website (deprescribing.org) where the app was promoted. We calculated total app downloads, monthly active users, and guideline-specific page views. Users were invited to complete the embedded Information Assessment Method (IAM) Questionnaire to obtain feedback on the value of information presented on the Deprescribing Channel. RESULTS: Between March 2, 2019 and November 30, 2019, we documented 9,454 page views of the promotional web page across 40 countries. The Deprescribing Channel was downloaded 3,256 times with an average of 464 monthly users. In total, the guidelines on this channel were accessed 14,377 times with 49,721 views across all guideline pages. Thirty-seven IAM questionnaires were completed. Thirty-two responses indicated this deprescribing information was relevant for at least one of their patients. Regarding educational outcomes, 22 responses were of learning something new and/or being motivated to learn more. CONCLUSION: We documented international interest in a mobile app providing continuing education on deprescribing. App users generated sustained page views over the study period. Feedback from a small number of users was positive with the majority finding the content relevant, educational, and applicable to patient care. Further work is needed to improve the usability of the embedded feedback questionnaire and to evaluate its value in supporting learning.
INTRODUCTION: We developed a new channel on a mobile app as a continuing education tool to augment the use of deprescribing guideline content in clinical practice. In this research brief, we describe the reach and adoption of channel content, as well as user feedback. METHODS: Using Google Analytics, we counted page views of the website (deprescribing.org) where the app was promoted. We calculated total app downloads, monthly active users, and guideline-specific page views. Users were invited to complete the embedded Information Assessment Method (IAM) Questionnaire to obtain feedback on the value of information presented on the Deprescribing Channel. RESULTS: Between March 2, 2019 and November 30, 2019, we documented 9,454 page views of the promotional web page across 40 countries. The Deprescribing Channel was downloaded 3,256 times with an average of 464 monthly users. In total, the guidelines on this channel were accessed 14,377 times with 49,721 views across all guideline pages. Thirty-seven IAM questionnaires were completed. Thirty-two responses indicated this deprescribing information was relevant for at least one of their patients. Regarding educational outcomes, 22 responses were of learning something new and/or being motivated to learn more. CONCLUSION: We documented international interest in a mobile app providing continuing education on deprescribing. App users generated sustained page views over the study period. Feedback from a small number of users was positive with the majority finding the content relevant, educational, and applicable to patient care. Further work is needed to improve the usability of the embedded feedback questionnaire and to evaluate its value in supporting learning.
Authors: Borja Martínez-Pérez; Isabel de la Torre-Díez; Miguel López-Coronado; Beatriz Sainz-de-Abajo; Montserrat Robles; Juan Miguel García-Gómez Journal: J Med Syst Date: 2014-01-08 Impact factor: 4.460
Authors: Barbara Farrell; Kevin Pottie; Wade Thompson; Taline Boghossian; Lisa Pizzola; Farah Joy Rashid; Carlos Rojas-Fernandez; Kate Walsh; Vivian Welch; Paul Moayyedi Journal: Can Fam Physician Date: 2017-05 Impact factor: 3.275
Authors: June C Carroll; Roland Grad; Judith E Allanson; Pierre Pluye; Joanne A Permaul; Nicholas Pimlott; Brenda J Wilson Journal: J Contin Educ Health Prof Date: 2016 Impact factor: 1.355
Authors: Barbara Farrell; Daniel Dilliott; Lisa Richardson; James Conklin; Lisa M McCarthy; Lalitha Raman-Wilms Journal: Can Pharm J (Ott) Date: 2022-02-14